Regulation of macrophage function in tumors: the multifaceted role of NF-κB

被引:196
作者
Hagemann, Thorsten [2 ]
Biswas, Subhra K. [3 ]
Lawrence, Toby [2 ]
Sica, Antonio [4 ,5 ]
Lewis, Claire E. [1 ]
机构
[1] Univ Sheffield, Sch Med, Acad Unit Pathol, Sheffield S10 2RX, S Yorkshire, England
[2] Barts & London Queen Marys Sch Med & Dent, Ctr Canc & Inflammat, Inst Canc, London, England
[3] Agcy Sci Technol & Res, Lab Human Innate Immun, Singapore Immunol Network, Inst Biomed Sci, Singapore, Singapore
[4] IRCCS, Ist Clin Humanitas, Milan, Italy
[5] Univ Piemonte Orientale, DiSCAFF, Novara, Italy
基金
英国医学研究理事会;
关键词
TOLL-LIKE RECEPTORS; INDUCED GENE-EXPRESSION; NITRIC-OXIDE SYNTHASE; SUPPRESSOR-CELLS; MYELOID CELLS; IKK-BETA; ALTERNATIVE ACTIVATION; CYCLOOXYGENASE-2; GENE; TRANSCRIPTION FACTORS; IMMUNE DYSFUNCTION;
D O I
10.1182/blood-2008-12-172825
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pivotal role of tumor-associated macrophages (TAMs) in tumor progression is now well established. TAMs have been shown to influence multiple steps in tumor development including the growth, survival, invasion, and metastasis of tumor cells as well as angiogenesis and lymphangiogenesis in tumors. The molecular circuits that polarize TAMs toward such a protumoral phenotype are now the focus of intense investigation. The transcription factor, nuclear factor-kappa B (NF-kappa B), is a master regulator of many cellular processes and been shown to regulate various pathways that impact on the function of TAMs. Much evidence for this has come from the use of elegant transgenic murine tumor models in which modification of single components of the NF-kappa B signaling pathway has been shown to regulate the pro-tumor repertoire of TAMs. Here, we outline this evidence and attempt to reconcile the various views that have emerged recently over the exact role of NF-kappa B in this phenomenon. (Blood. 2009; 113:3139-3146)
引用
收藏
页码:3139 / 3146
页数:8
相关论文
共 92 条
  • [1] Novel candidate genes for atherosclerosis are identified by representational difference analysis-based transcript profiling of cholesterol-loaded macrophages
    Andersson, T
    Boräng, S
    Larsson, M
    Wirta, V
    Wennborg, A
    Lundeberg, J
    Odeberg, J
    [J]. PATHOBIOLOGY, 2001, 69 (06) : 304 - 314
  • [2] Cancer and the chemokine network
    Balkwill, F
    [J]. NATURE REVIEWS CANCER, 2004, 4 (07) : 540 - 550
  • [3] Smoldering and polarized inflammation in the initiation and promotion of malignant disease
    Balkwill, F
    Charles, KA
    Mantovani, A
    [J]. CANCER CELL, 2005, 7 (03) : 211 - 217
  • [4] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [5] BALKWILL F, 1987, LANCET, V2, P1229
  • [6] Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells
    Banerjee, A
    Gugasyan, R
    McMahon, M
    Gerondakis, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (09) : 3274 - 3279
  • [7] The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
    Bingle, L
    Brown, NJ
    Lewis, CE
    [J]. JOURNAL OF PATHOLOGY, 2002, 196 (03) : 254 - 265
  • [8] A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)
    Biswas, SK
    Gangi, L
    Paul, S
    Schioppa, T
    Saccani, A
    Sironi, M
    Bottazzi, B
    Doni, A
    Vincenzo, B
    Pasqualini, F
    Vago, L
    Nebuloni, M
    Mantovani, A
    Sica, A
    [J]. BLOOD, 2006, 107 (05) : 2112 - 2122
  • [9] Plasticity of macrophage function during tumor progression: Regulation by distinct molecular mechanisms
    Biswas, Subhra K.
    Sica, Antonio
    Lewis, Claire E.
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (04) : 2011 - 2017
  • [10] Regulation of an essential innate immune response by the p50 subunit of NF-κB
    Bohuslav, J
    Kravchenko, VV
    Parry, GCN
    Erlich, JH
    Gerondakis, S
    Mackman, N
    Ulevitch, RJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (09) : 1645 - 1652